Nukkleus Stock Analysis
NUKK Stock | USD 1.79 0.13 7.83% |
Nukkleus is fairly valued with Real Value of 1.72 and Hype Value of 1.9. The main objective of Nukkleus stock analysis is to determine its intrinsic value, which is an estimate of what Nukkleus is worth, separate from its market price. There are two main types of Nukkleus' stock analysis: fundamental analysis and technical analysis.
The Nukkleus stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Nukkleus |
Nukkleus Stock Analysis Notes
About 35.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.69. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Nukkleus recorded a loss per share of 19.36. The entity had not issued any dividends in recent years. The firm had 1:8 split on the 24th of October 2024. Nukkleus Inc., a financial technology company, focuses on providing software and technology solutions for retail foreign exchange trading industry worldwide. Nukkleus Inc. operates as a subsidiary of Global Elite Holdings Ltd. Nukkleus operates under SoftwareApplication classification in the United States and is traded on OTC Exchange. It employs 12 people. To find out more about Nukkleus contact Emil Assentato at 212-791-4663 or learn more at https://www.nukk.com.Nukkleus Quarterly Total Revenue |
|
Nukkleus Investment Alerts
Nukkleus had very high historical volatility over the last 90 days | |
Nukkleus may become a speculative penny stock | |
Nukkleus was previously known as Brilliant Acquisition Corp and was traded on NASDAQ Exchange under the symbol BRLI. | |
Nukkleus currently holds 3.65 M in liabilities. Nukkleus has a current ratio of 0.22, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Nukkleus' use of debt, we should always consider it together with its cash and equity. | |
The entity reported the previous year's revenue of 16.22 M. Net Loss for the year was (11.85 M) with loss before overhead, payroll, taxes, and interest of (661.4 K). | |
Nukkleus has a poor financial position based on the latest SEC disclosures | |
About 35.0% of the company outstanding shares are owned by corporate insiders | |
Latest headline from news.google.com: Nukkleus Inc. issues new shares to single investor By Investing.com - Investing.com |
Nukkleus Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.8 M.Nukkleus Profitablity
The company has Profit Margin (PM) of (2.53) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (7.94) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $7.94.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (1.41) | (1.48) | |
Return On Capital Employed | (1.18) | (1.12) | |
Return On Assets | (0.79) | (0.83) | |
Return On Equity | (1.71) | (1.62) |
Management Efficiency
Nukkleus has return on total asset (ROA) of (1.1502) % which means that it has lost $1.1502 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (7.4205) %, meaning that it created substantial loss on money invested by shareholders. Nukkleus' management efficiency ratios could be used to measure how well Nukkleus manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -1.48. Return On Capital Employed is expected to rise to -1.12 this year. Total Current Liabilities is expected to rise to about 9 M this year. Liabilities And Stockholders Equity is expected to rise to about 22.2 M this yearLast Reported | Projected for Next Year | ||
Book Value Per Share | 1.00 | 1.05 | |
Tangible Book Value Per Share | 0.33 | 0.35 | |
Enterprise Value Over EBITDA | (47.94) | (50.34) | |
Price Book Value Ratio | 48.78 | 51.21 | |
Price Fair Value | 48.78 | 51.21 | |
Enterprise Value Multiple | (47.94) | (50.34) | |
Enterprise Value | 534.1 M | 273.9 M |
Understanding the management dynamics of Nukkleus allows us to gauge its ability to sustain growth and profitability. This comprehensive analysis aids in determining the stock's value.
Operating Margin (7.94) | Profit Margin (2.53) | Beta (0.32) | Return On Assets (1.15) | Return On Equity (7.42) |
Technical Drivers
As of the 2nd of December, Nukkleus secures the Mean Deviation of 7.44, risk adjusted performance of 0.0143, and Downside Deviation of 9.2. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nukkleus, as well as the relationship between them.Nukkleus Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Nukkleus middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Nukkleus. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Nukkleus Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nukkleus insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nukkleus' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Nukkleus insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Emil Assentato over three months ago Disposition of 200000000 shares by Emil Assentato of Nukkleus subject to Rule 16b-3 | ||
Emil Assentato over six months ago Acquisition by Emil Assentato of 157500000 shares of Nukkleus subject to Rule 16b-3 |
Nukkleus Outstanding Bonds
Nukkleus issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Nukkleus uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Nukkleus bonds can be classified according to their maturity, which is the date when Nukkleus has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
Boeing Co 2196 Corp BondUS097023DG73 | View | |
NuStar Logistics 5625 Corp BondUS67059TAE55 | View | |
NUSTAR LOGISTICS L Corp BondUS67059TAG04 | View | |
NuStar Logistics 6 Corp BondUS67059TAF21 | View | |
NUSTAR LOGISTICS L Corp BondUS67059TAH86 | View | |
US67052NAB10 Corp BondUS67052NAB10 | View | |
BNP Paribas FRN Corp BondUSF1R15XK367 | View |
Nukkleus Predictive Daily Indicators
Nukkleus intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Nukkleus stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Nukkleus Forecast Models
Nukkleus' time-series forecasting models are one of many Nukkleus' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Nukkleus' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Nukkleus Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Nukkleus prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Nukkleus shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Nukkleus. By using and applying Nukkleus Stock analysis, traders can create a robust methodology for identifying Nukkleus entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (0.18) | (0.19) | |
Operating Profit Margin | (0.18) | (0.19) | |
Net Loss | (0.18) | (0.19) |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Nukkleus to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Equity Search Now
Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets |
All Next | Launch Module |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nukkleus. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. For more information on how to buy Nukkleus Stock please use our How to buy in Nukkleus Stock guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nukkleus. If investors know Nukkleus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nukkleus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (19.36) | Revenue Per Share 7.024 | Quarterly Revenue Growth (0.97) | Return On Assets (1.15) | Return On Equity (7.42) |
The market value of Nukkleus is measured differently than its book value, which is the value of Nukkleus that is recorded on the company's balance sheet. Investors also form their own opinion of Nukkleus' value that differs from its market value or its book value, called intrinsic value, which is Nukkleus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nukkleus' market value can be influenced by many factors that don't directly affect Nukkleus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nukkleus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nukkleus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nukkleus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.